Phase II Trial of Combination Therapy With Bevacizumab and S-1 in Elderly Patients With Unresectable or Recurrent Colorectal Cancer (BASIC)

ABSTRACT: The purpose of this study is to determine whether S-1 and bevacizumab are safe in the treatment of unresectable or recurrent colorectal cancer

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2047230 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR